Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Revenue: 2014-2025

Historic Revenue for Ascendis Pharma A (ASND) over the last 12 years, with Sep 2025 value amounting to $249.7 million.

  • Ascendis Pharma A's Revenue rose 293.22% to $249.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $720.7 million, marking a year-over-year increase of 103.23%. This contributed to the annual value of $393.6 million for FY2024, which is 37.15% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Revenue of $249.7 million as of Q3 2025, which was up 39.60% from $178.9 million recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Revenue peaked at $249.7 million during Q3 2025, and registered a low of $899,852 during Q1 2021.
  • Over the past 3 years, Ascendis Pharma A's median Revenue value was $104.2 million (recorded in 2024), while the average stood at $110.5 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Revenue crashed by 63.37% in 2021, and later spiked by 1,074.55% in 2022.
  • Over the past 5 years, Ascendis Pharma A's Revenue (Quarterly) stood at $5.6 million in 2021, then surged by 316.97% to $23.4 million in 2022, then spiked by 534.29% to $148.2 million in 2023, then rose by 25.44% to $185.8 million in 2024, then surged by 293.22% to $249.7 million in 2025.
  • Its Revenue stands at $249.7 million for Q3 2025, versus $178.9 million for Q2 2025 and $106.2 million for Q1 2025.